Hims & Hers Health Inc.
HIMS | NYSE
$27.68
-$1.99 (-6.71%)
At close: Oct 30, 2026, 4:00 PM ET
$28.07
+$0.39 (+1.41%)
Pre-market:
Nov 2, 2026, 6:02 AM ET
Company Profile
Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrators, and lubricants. Hair Care: offering specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Beyond direct sales, Hims & Hers also distributes health and wellness products via wholesale partnerships. The company's headquarters are located in San Francisco, California.
Key Executives
| Name | Position |
|---|---|
| Andrew Dudum | Co-Founder, Chairman & Chief Executive Officer |
| Mike Chi | Chief Operating Officer |
| Mohamed ElShenawy | Chief Technology Officer |
| Oluyemi Okupe | Chief Financial Officer |
| Soleil Teubner Boughton | Chief Legal Officer & Corporate Secretary |
| Deborah Autor | Chief Policy Officer & Director |
| Irene A. Becklund | Chief Accounting Officer |
| Kathryn H. Beiser | Chief Communications Officer |
| Patrick Carroll | Global Chief Medical Officer |
| William James Newby | Senior Director of Investor Relations |
Hims & Hers Health Inc.
| Country | United States |
| IPO Date | Sep 13, 2019 |
| Industry | Medical - Care Facilities |
| Sector | Healthcare |
| Employees | 2,442 |
| CEO | Andrew Dudum |
Contact Details
2269 Chestnut Street San Francisco,
California 94123 United States
Stock Details
| Ticker Symbol | HIMS |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001773751 |
| CUSIP Number | 433000106 |
| ISIN Number | US4330001060 |
| SIC Code | 8011 |
Recent News
- 3 days ago / zacks.comHims & Hers Health, Inc. (HIMS) Gains As Market Dips: What You Should Know
- 6 days ago / zacks.comInvestors Heavily Search Hims & Hers Health, Inc. (HIMS): Here is What You Need to Know
- 10 days ago / zacks.comHims & Hers Health, Inc. (HIMS) Declines More Than Market: Some Information for Investors
- 10 days ago / benzinga.comHims & Hers Defends Subscription Practices And Privacy Disclosures Against Lawsuit
- 13 days ago / invezz.comHims & Hers stock rises 5% as company launches men's weight care in Germany
- 14 days ago / fool.comHims Is Reaching the Three Million Member Milestone
- 17 days ago / zacks.comHims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know
- 19 days ago / zacks.comHims & Hers Health, Inc. (HIMS) Suffers a Larger Drop Than the General Market: Key Insights
- 19 days ago / zacks.comHims & Hers Expands Australian Women's Health Platform With Hers
- 20 days ago / seekingalpha.comHims & Hers Health: The Bullish Case Is Hard To Forecast, But It Is Asymmetrical
Add to Watchlist
Select watchlists to add or remove HIMS